AU7383696A - Use of il-4 to treat psoriasis - Google Patents

Use of il-4 to treat psoriasis

Info

Publication number
AU7383696A
AU7383696A AU73836/96A AU7383696A AU7383696A AU 7383696 A AU7383696 A AU 7383696A AU 73836/96 A AU73836/96 A AU 73836/96A AU 7383696 A AU7383696 A AU 7383696A AU 7383696 A AU7383696 A AU 7383696A
Authority
AU
Australia
Prior art keywords
treat psoriasis
psoriasis
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73836/96A
Inventor
Jan E De Vries
Maureen C Howard
Edwin A. Peets
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU7383696A publication Critical patent/AU7383696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU73836/96A 1995-10-11 1996-10-08 Use of il-4 to treat psoriasis Abandoned AU7383696A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US508195P 1995-10-11 1995-10-11
US005081 1995-10-11
US62477896A 1996-03-27 1996-03-27
US624778 1996-03-27
PCT/US1996/015749 WO1997013525A1 (en) 1995-10-11 1996-10-08 Use of il-4 to treat psoriasis

Publications (1)

Publication Number Publication Date
AU7383696A true AU7383696A (en) 1997-04-30

Family

ID=26673900

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73836/96A Abandoned AU7383696A (en) 1995-10-11 1996-10-08 Use of il-4 to treat psoriasis

Country Status (2)

Country Link
AU (1) AU7383696A (en)
WO (1) WO1997013525A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7895000A (en) * 1999-10-19 2001-04-30 Kevin C Kain Products and methods for activating ppargamma-rxr and up-regulating monocyte/macrophage cd36 for the treatment of malaria
WO2023072871A1 (en) * 2021-10-25 2023-05-04 Ellennbe Gmbh Combined use of immunomodulatory substances and peripheral blood mononuclear cells in treating and/or preventing an inflammatory disease, immunological disease and/or autoimmunological disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0502080A4 (en) * 1989-11-21 1993-02-10 The University Of Melbourne Anti-inflammatory compositions and methods

Also Published As

Publication number Publication date
WO1997013525A1 (en) 1997-04-17

Similar Documents

Publication Publication Date Title
AU6797094A (en) Cosmetic treatment of substrates
AU7443496A (en) Treatment of migraine
AU1173195A (en) Treatment of immunoregulatory disorders
AU7650396A (en) Treatment and prophylaxis of osteoporosis
AUPM761094A0 (en) Treatment of hides
AU1115095A (en) Treatment of cellulose
AU6328696A (en) Treatment of hemoglobinopathies
AU7296396A (en) Absorption of water
AU3236093A (en) The use of ob-101 to treat inflammation
AU2058697A (en) Treatment of sleep disorders
AU3235693A (en) The use of ob-104 to treat inflammation
AU4704797A (en) Use of benzopyranols to treat neurological disorders
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU2265695A (en) The use of sertraline to treat cancer patients
AU4220193A (en) Deazaaminopterins for treatment of inflammation
AU2548095A (en) Human inhibitor of apoptosis gene 1
AU3477093A (en) 17beta -hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones useful to treat baldness
AU7565894A (en) Acupuncture treatment of common baldness
AU6397794A (en) Use of platelet factor 4 to treat inflammatory diseases
AU6829696A (en) Treatment of solutions
AU7383696A (en) Use of il-4 to treat psoriasis
AU4546096A (en) Treatment of waste
AU6460696A (en) Use of n-cyclohexyl benzamides for treating bowel disorders
AU6922994A (en) Use of acylcarnitin to treat illnesses caused by aids
AU2992295A (en) Therapeutic method and compounds of use therein